- Kristi Powers
Choose the health content that’s right for you, and get it delivered right in your inbox.
Patients with the most common type of heart arrhythmia have a promising new treatment option available only in Central Florida at the AdventHealth Heart, Lung and Vascular Institute. The Pulse Field Ablation (PFA) procedure is for atrial fibrillation (AFib) patients and is designed to help them maintain a normal rhythm. This spring, AdventHealth led the inaugural Pulse Field Ablation (PFA) procedure in Central Florida and other patients have followed with the same success.
“The procedure was quick, and the recovery was fast,” said Kroy Crofoot who underwent the PFA procedure at AdventHealth Orlando in July. “I went in at 9 am, went home by 4 pm and was walking by the end of the day.”
Crofoot, who is a local furniture store owner, says he has more energy now than before the PFA procedure and he was back at work the next day, but with lifting restrictions.
“PFA is a targeted treatment that’s a safer, more efficient approach than traditional methods like radiofrequency ablation that uses heat. Heat can inadvertently damage surrounding tissues,” said Dr. Naushad Shaik, electrophysiologist and EP medical director at the AdventHealth Heart, Lung and Vascular Institute. “Our patients are learning about this new treatment and asking for it - and it has improved outcomes.”
PFA works by delivering short-duration electrical pulses to the heart tissue. The energy from the pulses kills the cells in only the cardiac tissue causing the irregular heart rate and rhythm, therefore restoring the heart to a more normal condition.
According to the Centers for Disease Control and Prevention (CDC), AFib is responsible for more than 454,000 hospitalizations and roughly 158,000 deaths each year in the U.S. In addition, the CDC forecasts 12.1 million people in the United States will have AFib by 2030.
The 67-year-old credits his son, Ivan, for nudging him to get checked out by a cardiologist.
“I thought I would get a clean bill of health, instead I was told I had AFib,” said Crofoot.
He also gives high marks to Dr. Shaik and his team for helping him stay active at his work, moving furniture, and in his off time, playing tennis and pickleball.
New PFA procedure on Healthy Connections TV
“This is a minimally invasive procedure done with tiny tubes placed in through the groin and into your heart and is performed in under an hour,” Shaik recently told Healthy Connections. “Another benefit of the PFA procedure is patients are able to come off of some of their medications.”
At his next check-up appointment, Crofoot says he hopes to be able to stop taking his blood thinner medication. For more information on the new PFA procedure, call Call407-931-5040.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...